Richard Craven of CliniSys considers some of the big developments in pathology and how technology will help laboratories to confront current challenges while preparing for the future of personalised medicine.
It is impossible to turn on the TV news or to click a headline on a newspaper website without hearing about the immense pressure that the NHS is facing.
The health and care system has come out of the Covid-19 pandemic with a huge backlog of elective care that has pushed waiting lists to 6.5 million and rising. At the same time, it is facing capacity constraints that are showing up as ambulance queues and concern about access to primary care.
Pathology services are critical to tackling these challenges. I’m not
sure this is widely understood; but
NHS laboratories conduct 1.2 billion tests a year, and those tests are critical to diagnosis and treatment, to monitoring the progression of disease, and to ensuring the safety of blood transfusion.
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.